Vanda Pharmaceuticals/$VNDA
About Vanda Pharmaceuticals
Ticker
Industry
Employees
VNDA Metrics
$255M
-
-$0.29
0.77
-
Price and volume
Market cap
$255M
Beta
0.77
52-week high
$6.75
52-week low
$3.46
Average daily volume
618K
Financial strength
Current ratio
4.853
Quick ratio
4.703
Long term debt to equity
1.014
Total debt to equity
1.467
Interest coverage (TTM)
-41.59%
Management effectiveness
Return on assets (TTM)
-3.64%
Return on equity (TTM)
-3.02%
Valuation
Price to revenue (TTM)
1.33
Price to book
0.47
Price to tangible book (TTM)
0.6
Price to free cash flow (TTM)
-2.062
Growth
Revenue change (TTM)
-9.91%
Earnings per share change (TTM)
-240.92%
3-year revenue growth (CAGR)
-10.73%
3-year earnings per share growth (CAGR)
-21.50%
What the Analysts think about VNDA
Analyst Ratings
VNDA Financial Performance
Income Statement
Q3 24
QoQ growth
$37B
-39.75%
$45B
107.52%
37.65%
6.78%
VNDA Earnings Performance
Earnings per share (EPS)
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
$3.69
$2.85
$2.45
$2.42
-
$3.55
$2.61
$2.05
$2.31
$3.94
3.94%
9.20%
19.51%
4.63%
-
VNDA News
FAQs
What’s the current market cap for Vanda Pharmaceuticals stock?
What is the P/E ratio for Vanda Pharmaceuticals stock?
Does Vanda Pharmaceuticals stock pay dividends?
No, Vanda Pharmaceuticals (VNDA) stock does not pay dividends to its shareholders as of January 15, 2025.
When is the next Vanda Pharmaceuticals dividend payment date?
Vanda Pharmaceuticals (VNDA) stock does not pay dividends to its shareholders.
What is the beta indicator for Vanda Pharmaceuticals?
Vanda Pharmaceuticals (VNDA) has a beta rating of 0.77. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.